EBLN1

gene
On this page

Summary

EBLN1 (endogenous Bornavirus like nucleoprotein 1, HGNC:39430) is a protein-coding gene on chromosome 10p12.31, encoding Endogenous Bornavirus-like nucleoprotein 1 (P0CF75). May act as an RNA-binding protein.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 56 total
  • MANE Select transcript: NM_001394757

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:39430
Approved symbolEBLN1
Nameendogenous Bornavirus like nucleoprotein 1
Location10p12.31
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000223601
Ensembl biotypeprotein_coding
OMIM613249
Entrez340900

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000422359, ENST00000939589

RefSeq mRNA: 2 — MANE Select: NM_001394757 NM_001199938, NM_001394757

CCDS: CCDS60498

Canonical transcript exons

ENST00000422359 — 3 exons

ExonStartEnd
ENSE000017648332220847522210027
ENSE000039244452221791622218015
ENSE000039358642221284222212965

Expression profiles

Bgee: expression breadth tissue_specific, 7 present calls, max score 96.65.

Top tissues by expression

101 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099196.65gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.81gold quality
right testisUBERON:000453459.02gold quality
testisUBERON:000047358.33gold quality
left testisUBERON:000453358.30gold quality
granulocyteCL:000009439.85gold quality
bone marrow cellCL:000209238.50gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
mucosa of stomachUBERON:000119935.85silver quality
ganglionic eminenceUBERON:000402335.49gold quality
bone marrowUBERON:000237134.19gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
ectocervixUBERON:001224931.99gold quality
uterine cervixUBERON:000000231.74gold quality
sural nerveUBERON:001548830.93gold quality
olfactory segment of nasal mucosaUBERON:000538630.90silver quality
fallopian tubeUBERON:000388930.42gold quality
right uterine tubeUBERON:000130230.25gold quality
stromal cell of endometriumCL:000225529.87gold quality
substantia nigraUBERON:000203829.75silver quality
left uterine tubeUBERON:000130329.57gold quality
Brodmann (1909) area 9UBERON:001354029.04gold quality
leukocyteCL:000073828.90gold quality
myometriumUBERON:000129628.71gold quality
liverUBERON:000210728.32gold quality
monocyteCL:000057628.29gold quality
duodenumUBERON:000211428.14gold quality
islet of LangerhansUBERON:000000628.09gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.80

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • Our results provide evidence for new loci influencing abdominal visceral (BBS9, ADCY8, KCNK9) and subcutaneous (MLLT10/DNAJC1/EBLN1) fat, and confirmed a locus (THNSL2) previously reported to be associated with abdominal fat in women. (PMID:26480920)
  • Numerous genes were dysregulated by Endogenous bornavirus-like nucleoprotein 1 silencing, some of which may be key target genes of Rho family GTPase 3, oncostatin M receptor, and cAMP responsive element binding protein 3-like 2 protein. (PMID:27023521)
  • human EBLN1 possesses important cellular functions within human cells. (PMID:27739501)

Cross-species orthologs

0 orthologs

Paralogs (1): EBLN2 (ENSG00000255423)

Protein

Protein identifiers

Endogenous Bornavirus-like nucleoprotein 1P0CF75 (reviewed: P0CF75)

Alternative names: Endogenous Borna-like N element-1

All UniProt accessions (1): P0CF75

UniProt curated annotations — full annotation on UniProt →

Function. May act as an RNA-binding protein. Highly homologous to the bornavirus nucleocapsid N protein that binds viral RNA and oligomerizes.

Tissue specificity. Expression detected by RT-PCR in a few cell lines, including OL, HEK293T and MOLT-4. Not observed in HeLa cells.

Miscellaneous. Bornavirus is a non-retroviral RNA virus that does not generate DNA forms during viral replication. Therefore, integration of EBLN-1 must have occur through a mechanism relying on an endogenous reverse transcriptase activity.

RefSeq proteins (2): NP_001186867, NP_001381686* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR009441P40_nucleoprot_BD-virFamily
IPR015969P40_nucleoprot_sub1_BD-virHomologous_superfamily
IPR015970P40_nucleoprot_sub2_BD-virHomologous_superfamily
IPR036260P40_nucleoprot_sf_BD-virHomologous_superfamily

Pfam: PF06407

UniProt features (5 total): sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CF75-F184.450.61

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 3 (showing top): chr10p12, PAX3_TARGET_GENES, SUPT16H_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

150 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
EBLN1LIME1Q9H400518
EBLN1C16orf96A6NNT2505
EBLN1AP1S1P61966493
EBLN1FAM194CQ8ND61479
EBLN1ZNF284Q2VY69476
EBLN1FANCCQ00597413
EBLN1YAE1Q9NRH1400
EBLN1LRRC46Q96FV0377
EBLN1MYCBPAPQ8TBZ2370
EBLN1KRTAP2-3P0C7H8353
EBLN1V9GYV3V9GYV3353
EBLN1ETNK1Q9HBU6348
EBLN1GPR45Q9Y5Y3325
EBLN1TLL2Q9Y6L7311
EBLN1WDR46O15213308

IntAct

3 interactions, top by confidence:

ABTypeScore
EBLN1TTNpsi-mi:“MI:0915”(physical association)0.400
EBLN1STAG2psi-mi:“MI:0915”(physical association)0.400

BioGRID (3): EBLN1 (Affinity Capture-MS), STAG2 (Proximity Label-MS), TTN (Proximity Label-MS)

ESM2 similar proteins: A0A345BJN9, A1XFV8, A3DRP6, A3RM21, A7WNB1, A8C8K0, B2ZCQ0, F5HDY6, P03499, P04858, P07051, P08593, P08671, P09280, P0C772, P0C773, P0CF75, P0DOE1, P13140, P14155, P21431, P22046, P31964, P47146, P52510, Q00151, Q04551, Q07458, Q07FH9, Q0GBY2, Q197F9, Q1I0U5, Q289M1, Q5K2K5, Q5NDN1, Q65YU7, Q6P5S2, Q6XSW4, Q6XTD8, Q6XTK0

Diamond homologs: P0C796, P0C797, P0CF75, Q6P2I7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

56 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance54
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

193 predictions. Top by Δscore:

VariantEffectΔscore
10:22209350:C:CTacceptor_gain0.6800
10:22209484:G:Adonor_gain0.6100
10:22209447:TTC:Tdonor_gain0.5600
10:22209080:C:CCacceptor_gain0.5500
10:22209161:GTACC:Gdonor_loss0.5100
10:22209162:TACC:Tdonor_loss0.5100
10:22209163:A:ACdonor_gain0.5100
10:22209163:ACCTT:Adonor_loss0.5100
10:22209164:C:CCdonor_gain0.5100
10:22209164:C:CGdonor_loss0.5100
10:22209349:C:Gacceptor_gain0.5100
10:22209032:C:CTacceptor_gain0.4900
10:22208973:C:CTacceptor_gain0.4800
10:22209261:T:Adonor_gain0.4800
10:22208976:T:Cacceptor_gain0.4600
10:22209351:A:Tacceptor_gain0.4600
10:22209079:GCT:Gacceptor_gain0.4500
10:22209163:AC:Adonor_gain0.4500
10:22209164:CC:Cdonor_gain0.4500
10:22209350:C:Tacceptor_gain0.4500
10:22209448:T:Adonor_gain0.4500
10:22209465:T:TAdonor_gain0.4500
10:22209206:C:Gacceptor_gain0.4400
10:22209077:TTG:Tacceptor_gain0.4300
10:22208981:G:GCacceptor_gain0.4200
10:22209080:C:Aacceptor_gain0.4200
10:22209205:T:TGacceptor_gain0.4100
10:22209033:A:Tacceptor_gain0.4000
10:22209076:GTTGC:Gacceptor_gain0.4000
10:22209077:TTGCT:Tacceptor_gain0.4000

AlphaMissense

2420 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:22209090:G:CF298L0.932
10:22209090:G:TF298L0.932
10:22209092:A:GF298L0.932
10:22209741:A:CF81L0.922
10:22209741:A:TF81L0.922
10:22209743:A:GF81L0.922
10:22209255:G:CF243L0.902
10:22209255:G:TF243L0.902
10:22209257:A:GF243L0.902
10:22209768:A:CF72L0.897
10:22209768:A:TF72L0.897
10:22209770:A:GF72L0.897
10:22209192:A:CF264L0.874
10:22209192:A:TF264L0.874
10:22209194:A:GF264L0.874
10:22209489:G:CF165L0.873
10:22209489:G:TF165L0.873
10:22209491:A:GF165L0.873
10:22209027:A:CF319L0.869
10:22209027:A:TF319L0.869
10:22209029:A:GF319L0.869
10:22209894:A:CF30L0.864
10:22209894:A:TF30L0.864
10:22209896:A:GF30L0.864
10:22209342:A:CF214L0.856
10:22209342:A:TF214L0.856
10:22209344:A:GF214L0.856
10:22209036:A:CF316L0.854
10:22209036:A:TF316L0.854
10:22209038:A:GF316L0.854

dbSNP variants (sampled 300 via entrez): RS1000350251 (10:22210331 A>G), RS1000834713 (10:22215093 T>C), RS1001448761 (10:22210680 T>C), RS1001853304 (10:22208911 C>A,G,T), RS1001870101 (10:22215168 A>G), RS1001919703 (10:22210355 T>C), RS1001962018 (10:22217931 G>A), RS1002566736 (10:22208424 G>C), RS1002671631 (10:22217764 A>C), RS1003046846 (10:22211464 A>T), RS1003195834 (10:22208090 G>A,T), RS1003212263 (10:22219281 C>T), RS1003226317 (10:22212867 T>C), RS1003737828 (10:22219698 G>A), RS1003902965 (10:22215686 G>A,T)

Disease associations

OMIM: gene MIM:613249 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST003170_7Subcutaneous adipose tissue4.000000e-08
GCST007327_95Smoking status (ever vs never smokers)1.000000e-09
GCST007507_12Benign prostatic hyperplasia and lower urinary tract symptoms2.000000e-15
GCST010136_13Fruit consumption1.000000e-08
GCST010136_20Fruit consumption3.000000e-08
GCST010136_26Fruit consumption5.000000e-20
GCST010142_85Fish- and plant-related diet2.000000e-24
GCST011351_16Aspartate aminotransferase levels2.000000e-09

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004318smoking behavior
EFO:0008008lower urinary tract symptom
EFO:0008111diet measurement
EFO:0004736aspartate aminotransferase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
abrineincreases expression1
theaflavin-3,3’-digallateaffects expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): benign prostatic hyperplasia